EXPERT OPINION ON INVESTIGATIONAL DRUGS

所属栏目:SCI期刊 热度:184

EXPERT OPINION ON INVESTIGATIONAL DRUGS

EXPERT OPINION ON INVESTIGATIONAL DRUGS

期刊周期:Monthly
研究方向:医学
影响因子:4.031
通讯地址:INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
官网:http://www.tandfonline.com/toc/ieid20/current
投稿地址:https://mc.manuscriptcentral.com/eoid
审稿速度:较慢,6-12周

  中文简介

由Informa Pharmaceutical Science出版(原Ashley Publications)。ISSN: 1354 - 3784。《研究药物专家意见》(EOID)是一份经同行评审的月刊,评估药物研究的进展,从动物研究到新药物的推出。鼓励作者对审查中的研究现状发表专家意见,而不是简单地审查现有数据。每期杂志还包括社论、药物评价、临床试验报告、会议纪要和论文评价。观众包括制药行业的科学家、经理和决策者,以及与研发密切相关的其他人。用户包括美国、欧洲和日本的大多数主要制药公司,以及许多生物技术公司。研究药物的专家意见采用系统的方法进行覆盖,每个问题都集中在一个主要的治疗领域。

  英文简介

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3784.Expert Opinion on Investigational Drugs (EOID) is a monthly peer-reviewed journal, evaluating developments in pharmaceutical research, from animal studies through to the launch of a new medicine. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than simply reviewing the available data. Each issue of the journal also contains Editorials, Drug Evaluations, Clinical Trial Reports, Meeting Highlights and Paper Evaluations. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Investigational Drugs adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.

  近年期刊自引率趋势图

  JCR分区

JCR分区等级 JCR所属学科 分区 影响因子
Q1 PHARMACOLOGY & PHARMACY Q1 6.498

  近年期刊影响因子趋势图

  CiteScore数值

CiteScore SJR SNIP 学科类别 分区 排名 百分位
8.60 1.177 1.056 大类:Medicine 小类:Pharmacology (medical) Q1 22 / 255

91%

大类:Medicine 小类:Pharmacology Q1 48 / 303

84%

  相关医学SCI期刊推荐

SCI服务

搜论文知识网的海量职称论文范文仅供广大读者免费阅读使用! 冀ICP备15021333号-3